NRC HEALTH
For the period ended Jul 28, 2026. Filed Jul 28, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 28, 2026 · Filed Jul 28, 2026
Use the contents to explore the available documents and sections.
NRC$25.86+1.5%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA and Adjusted EBITDA Margin
| · · Three months endedJune 30, · · · Six months endedJune 30, · | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · 2026 · · · 2025 · · · 2026 · · · 2025 · | ||||||||||||||||
| Net income (loss) | | $(3,283) | | $(106) | | $(61) | | $5,681 | | |||||||
| Add back: | | | | | | | | | | | | | | | | |
| Depreciation and amortization | | | 2,121 | | | | 1,742 | | | | 4,290 | | | | 3,284 | |
| Interest expense | | | 1,321 | | | | 1,032 | | | | 2,576 | | | | 1,931 | |
| Income taxes | | | (1,254) | | | 687 | | | | (97) | | | 2,623 | | ||
| Management transition costs1 | | | 3,160 | | | | 6,640 | | | | 3,160 | | | | 6,640 | |
| Non-cash stock compensation | | | 7,371 | | | | 307 | | | | 8,979 | | | | 478 | |
| Adjusted EBITDA | | $9,436 | | | $10,302 | | | $18,847 | | | $20,637 | | ||||
| | | | | | | | | | | | | | | | | |
| Net income (loss) margin | | | (9)% | | | - | % | | | - | % | | | 8% | ||
| Adjusted EBITDA margin | | | 27% | | | 30% | | | 27% | | | 31% | ||||
| 1) | See 'Non-GAAP Financial Measures' above for a description of the composition of management transition costs and the change from prior period presentation. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.